Prostate Cancer - Results from #28320

Prostate-specific antigen kinetics and choline PET/CT in patients with biochemical relapse after primary treatment for prostate cancer - Abstract April 1, 2011

High-dose-rate brachytherapy combined with hypofractionated external beam radiotherapy for men with intermediate or high risk prostate cancer: Analysis of short- and medium-term urinary toxicity and biochemical control - Abstract April 1, 2011

A single center prospective study: Prediction of postoperative general quality of life, potency and continence after radical retropubic prostatectomy - Abstract April 1, 2011

Does hormone therapy exacerbate the adverse effects of radiotherapy in men with prostate cancer? A quality of life study - Abstract April 1, 2011

A contemporary analysis of outcomes of adenocarcinoma of the prostate with seminal vesicle invasion (pT3b) after radical prostatectomy - Abstract April 1, 2011

Overuse of imaging for staging low risk prostate cancer - Abstract April 1, 2011

A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range - Abstract April 1, 2011

The relationship between prostate specific antigen change and biopsy progression in patients with prostate cancer on active surveillance - Abstract April 1, 2011

Administrative data sets are inaccurate for assessing functional outcomes after radical prostatectomy - Abstract April 1, 2011

A biopsychosocial approach to sexual recovery after prostate cancer surgery: The role of grief and mourning - Abstract April 1, 2011

Pathologic stage of prostatic ductal adenocarcinoma at radical prostatectomy: Effect of percentage of the ductal component and associated grade of acinar adenocarcinoma - Abstract March 31, 2011

The diagnostic utility of novel immunohistochemical marker ERG in the workup of prostate biopsies with "atypical glands suspicious for cancer" - Abstract March 31, 2011

The predictability of T3 disease in staging MRI following prostate biopsy decreases in patients with high initial PSA and Gleason score - Abstract March 31, 2011

Androgen suppression strategies for prostate cancer: Is there an ideal approach? - Abstract March 31, 2011

The implication of initial 24-core transrectal prostate biopsy protocol on the detection of significant prostate cancer and high grade prostatic intraepithelial neoplasia - Abstract March 31, 2011

3D-conformal hypofractionated radiotherapy for prostate cancer with daily transabdominal ultrasonography prostate localization: Toxicity and outcome of a pilot study - Abstract March 31, 2011

Radical prostatectomy for high-risk clinically localized prostate cancer: A prospective single institution series - Abstract March 31, 2011

Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: The impact of time from surgery to recurrence - Abstract March 31, 2011

Imaging of prostate cancer with PET/CT and radioactively labeled choline derivates - Abstract March 31, 2011

Serum retinol and risk of prostate cancer - Abstract March 31, 2011

Page 1417 of 1436